Grant directory

Closed

Funds U.S. small businesses and their research institution partners conducting early-stage space technology R&D through NASA's Small Business Technology Transfer program.

Closed

Funds Stanford teams piloting and advancing validated health innovations through capital and hands-on operating support.

Closed

Funds Italian companies in southern regions to develop critical innovation in climate, health, and materials.

Closed

Pays up to 25 small consortia EUR 200,000 each to test the commercial exploitation potential of results that already came out of earlier Horizon Europe or Horizon 2020 Cluster 4 projects.

Closed

Awards $125K in cash, lab space and services to biotech startups pitching for investors.

Closed

Pays teams up to $10,000 each, plus six months of biotech mentoring, for drug-use research ideas.

Closed

Awards up to $75,000 and a 5-month accelerator to entrepreneurs building aging-research startups.

Closed

Supports Taiwan researchers with structured pathways in early-career academic excellence awards, from planning to deployment.

Closed

Supports rapid partnerships between United Kingdom businesses and academic teams to transfer innovation into commercialization.

Closed

Funds Australian businesses with up to A$1 million to commercialise novel, IP-heavy products, processes and services.

Closed

Funds lead optimization and in vivo testing for frontotemporal dementia candidates, including medicinal chemistry and preclinical studies.

Closed

Funds clinical trials of prophylactic vaccines against neglected tropical diseases such as schistosomiasis, leishmaniasis and leprosy in sub-Saharan Africa.

Closed

Funds organizations worldwide improving women’s health through integrated mental and physical wellbeing initiatives.

Closed

Funds work on the methodological problems that make trials of rapid-acting psychotropic drugs hard to interpret, and on sustaining the treatment afterwards.

Closed

Pays deep-tech start-ups, SMEs and research organisations a €300,000 lump sum in Stage 1, then up to €2.5 million in Stage 2, to push high-risk breakthrough innovations that lack commercial uptake toward real-world, demand-tested deployment.

Closed

Funds advanced postdoctoral researchers with substantial support to strengthen independent study in type 1 diabetes science.

Closed

Funds early clinical trials of therapies built from the molecules cells secrete rather than the cells themselves, aiming for an off-the-shelf alternative to cell therapy.

Closed

Funds Texas A&M teams translating early discoveries through commercialization support and enterprise readiness.

Closed

Funds EIT Knowledge and Innovation Communities delivering business plans, cross-KIC work and higher-education activities through EU grants.

Closed

Funds Swiss SMEs and start-ups already on the market to commercialise and scale innovation projects through Innosuisse direct grants.

Closed

Offers impact entrepreneurs a free 16-week mentorship and leadership fellowship.

Closed

Funds French organizations through ANR's broad flagship call in multiple priority research themes.

Closed

Funds accelerator support for Saudi research teams turning lab discoveries into market-ready products.

Closed

Funds research and pilots that help rural communities plan for and adapt to demographic decline and ageing populations.